PAB's latest stock split occurred on Oct 13, 2025

The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.

Before the split, PAB traded at 0.002 per share. Afterward, the share price was about 0.025.

The adjusted shares began trading on Oct 13, 2025. This was PAB's 8th stock split, following the previous one in Jul 31, 2025.

Last Splits:
Oct 13, 2025
1-for-15
Jul 31, 2025
31-for-22
Nov 3, 2021
481-for-479
Nov 11, 2020
147-for-146
Jul 1, 2020
1-for-1
Pre-Split Price
0.03 0.002
Post-Split Price
0.025
Before
After
Last Splits:
Oct 13, 2025
1-for-15
Jul 31, 2025
31-for-22
Nov 3, 2021
481-for-479
Nov 11, 2020
147-for-146
Jul 1, 2020
1-for-1

Patrys Ltd
Stock Splits History

PAB Stock Splits Timeline
Oct 13, 2025
Oct 13, 2025
Split 1-for-15
/0.066666666666667
Pre-Split Price
0.03 0.002
Post-Split Price
0.025
Before
After
Jul 31, 2025
Jul 31, 2025
Split 31-for-22
x1.4090909090909
Pre-Split Price
0.0236 0.0022
Post-Split Price
0.03
Before
After
Nov 3, 2021
Nov 3, 2021
Split 481-for-479
x1.0041753653445
Pre-Split Price
0.4343 0.041
Post-Split Price
0.4361
Before
After
Nov 11, 2020
Nov 11, 2020
Split 147-for-146
x1.0068493150685
Pre-Split Price
0.2448 0.0233
Post-Split Price
0.2347
Before
After
Jul 1, 2020
Jul 1, 2020
Split 1-for-1
/1
Pre-Split Price
0.1399 0.0133
Post-Split Price
0.1399
Before
After
Jan 17, 2018
Jan 17, 2018
Split 143-for-138
x1.036231884058
Pre-Split Price
0.2475 0.0244
Post-Split Price
0.2215
Before
After
Nov 19, 2013
Nov 19, 2013
Split 96-for-89
x1.0786516853933
Pre-Split Price
0.6675 0.0709
Post-Split Price
0.675
Before
After
Jul 1, 2009
Jul 1, 2009
Split 1-for-1
/1
Pre-Split Price
1.3558 0.1439
Post-Split Price
1.3558
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.13 0.13 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.41 8.41 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Dec 30, 2025
Adicet Bio Inc
NASDAQ:ACET
1-for-16
/16
0.4921 0.4921 USD 7.93 7.93 USD
Load More

Patrys Ltd
Glance View

Market Cap
9.2m AUD
Industry
Biotechnology

Patrys Ltd. engages in the commercialisation of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2007-07-13. The firm is engaged in developing the treatment of Glioblastoma (GBM) and Triple Negative Breast Cancer (TNBC). The firm has developed two forms of deoxymab 3E10, including PAX-DX1 and PAT-DX3. Its is also using the PAT-DX1 antibody to deliver nanoparticles carrying therapeutic payloads to the inside of cells. The firm is in the process of the first human clinical trial of PAT-DX1. Its two product candidates, PAT-DX2 and PAT-DX1-NP are under preclinical stage.

PAB Intrinsic Value
0.031 AUD
Undervaluation 12%
Intrinsic Value
Price
Back to Top